AMGN vs NHI · P/E 24, rev $10.05B vs P/E 22, rev $54.4M
Amgen Inc (AMGN) versus National Health Investors Inc (NHI) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
National Health Investors Inc (NHI) is a reit - healthcare facilities company listed on US.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported NHI revenue for 2024-12-31 was $54.4M. Net income was $136.6M. Revenue was up 11.5% from 2023-12-31 to 2024-12-31. NHI currently screens at market cap $3.31B and trailing P/E 22.4.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. NHI currently screens at market cap $3.31B and trailing P/E 22.4.
Not investment advice. Open the AMGN and NHI stock pages for the full models.
Not investment advice.